RHOA at the intersection of inflammation-driven and sporadic colorectal cancer - Takeaways - MDSpire

RHOA at the intersection of inflammation-driven and sporadic colorectal cancer

  • By

  • Sofia Elena Muccioli

  • Laura Hidalgo-García

  • Phuong A Ngo

  • Markus F Neurath

  • Rocío López-Posadas

  • July 9, 2026

  • 0 min

Share

  • 1

    Colorectal cancer (CRC) accounts for approximately 10% of all malignant tumors and is the second leading cause of cancer-related death globally.

  • 2

    Colitis-associated cancer (CAC) arises from chronic inflammation and has a worse prognosis compared to sporadic CRC.

  • 3

    RHOA, a small GTPase, plays a controversial role in cancer, acting as both a tumor promoter and suppressor depending on the context.

  • 4

    The genetic profiles of sporadic CRC and CAC differ, with distinct mutations and pathways involved in their development.

  • 5

    Understanding RHOA's role in CRC may help identify limitations in developing novel therapeutic targets and diagnostic strategies.

Original Source(s)

RHOA at the intersection of inflammation-driven and sporadic colorectal cancer

  • by Sofia Elena Muccioli, Laura Hidalgo-García, Phuong A Ngo, Markus F Neurath, Rocío López-Posadas

  • July 9, 2026

Related Content

Multi-scale information bottleneck with confidence-weighted decision fusion for robust breast ultrasound lesion classification

Identification and validation of prognostic genes associated with clear cell renal cell carcinoma: based on public whole transcriptome sequencing datasets

A phase II clinical trial of neoadjuvant chemotherapy combined with immunotherapy and different radiotherapy fractionation regimens in HR+/HER2- breast cancer